- Home
- VTRS vs NICE Comparison
VTRS vs NICE Comparison
Compare VTRS & NICE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTRS
- NICE
- Stock Information
- Founded
- VTRS 1961
- NICE 1986
- Country
- VTRS United States
- NICE Israel
- Employees
- VTRS N/A
- NICE N/A
- Industry
- VTRS Medicinal Chemicals and Botanical Products
- NICE Computer Software: Prepackaged Software
- Sector
- VTRS Health Care
- NICE Technology
- Exchange
- VTRS Nasdaq
- NICE Nasdaq
- Market Cap
- VTRS 11.8B
- NICE 10.3B
- IPO Year
- VTRS N/A
- NICE 1996
- Fundamental
- Price
- VTRS $10.61
- NICE $133.16
- Analyst Decision
- VTRS Hold
- NICE Buy
- Analyst Count
- VTRS 5
- NICE 13
- Target Price
- VTRS $10.40
- NICE $204.46
- AVG Volume (30 Days)
- VTRS 9.5M
- NICE 785.6K
- Earning Date
- VTRS 08-07-2025
- NICE 08-14-2025
- Dividend Yield
- VTRS 4.52%
- NICE N/A
- EPS Growth
- VTRS N/A
- NICE 39.25
- EPS
- VTRS N/A
- NICE 8.36
- Revenue
- VTRS $14,115,700,000.00
- NICE $2,838,467,000.00
- Revenue This Year
- VTRS N/A
- NICE $9.06
- Revenue Next Year
- VTRS $1.85
- NICE $6.74
- P/E Ratio
- VTRS N/A
- NICE $16.02
- Revenue Growth
- VTRS N/A
- NICE 11.39
- 52 Week Low
- VTRS $6.85
- NICE $127.00
- 52 Week High
- VTRS $13.55
- NICE $200.65
- Technical
- Relative Strength Index (RSI)
- VTRS 72.50
- NICE 33.33
- Support Level
- VTRS $8.74
- NICE $127.00
- Resistance Level
- VTRS $9.03
- NICE $148.96
- Average True Range (ATR)
- VTRS 0.32
- NICE 5.27
- MACD
- VTRS 0.17
- NICE -2.29
- Stochastic Oscillator
- VTRS 90.83
- NICE 14.57
About VTRS Viatris Inc.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
About NICE NICE Ltd
NICE Ltd is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.